Day: Smartbax
7 Questions
Smartbax: New antibiotics against superbugs
Smartbax develops innovative antibiotics against multi-resistant bacteria with a completely new mechanism of action: Instead of blocking processes, they cause germs to…
Deals
Smartbax receives 4.7 million euros
The Munich-based biotech startup Smartbax has secured €4.7 million in a pre-Series A round. The team plans to use the capital to further develop its antibiotics…
Deals
Smartbax closes seed round with 1.2 million euros
Smartbax is developing antibiotics against multi-resistant bacteria. The Munich-based biotech company has closed its seed round with €1.2 million.
